北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 663-668. doi: 10.3969/j.issn.1671-167X.2017.04.021

• 论著 • 上一篇    下一篇

CXCL16/CXCR6在类风湿关节炎成纤维样滑膜细胞中的表达及其在滑膜细胞增殖中的作用

张霞1,2,赵金霞1,孙琳1,刘湘源1△   

  1. (1. 北京大学第三医院风湿免疫科, 北京100191; 2. 北京协和医院免疫科, 北京100730)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 刘湘源 E-mail:liu-xiangyuan@263.net

Expression of CXCL16 /CXCR6 in fibroblast-like synoviocytes in rheumatoid arthritis and its role in synoviocyte proliferation

ZHANG Xia1,2, ZHAO Jin-xia1, SUN Lin1, LIU Xiang-yuan1△   

  1. (1. Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China; 2. Department of Rheumatology, Peking Union Medical Colledge, Beijing 100730, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: LIU Xiang-yuan E-mail:liu-xiangyuan@263.net

摘要: 目的:探讨趋化因子CXCL16及其受体CXCR6在类风湿关节炎(rheumatoid arthritis,RA)患者成纤维样滑膜细胞(fibroblast-like synoviocytes,FLS)中的表达及其对FLS增殖的作用。方法:纳入RA 8例、骨关节炎(osteoarthritis,OA)7例、健康对照3例,采用组织块贴壁方法体外分离培养人膝关节FLS,第3~5代细胞用于后续研究。Western blot方法检测CXCL16及其受体CXCR6在3组FLS的表达水平;不同浓度的重组人CXCL16(0、10、50、100、200 μg/L)刺激3组FLS后,细胞活性检测试剂盒-8(cell counting kit,CCK-8)检测FLS增殖水平;Western blot方法检测重组人CXCL16刺激后RA-FLS中pAKT/AKT水平;ELISA法检测重组人CXCL16刺激后RA-FLS培养上清中TNF-ɑ、IL-6、MMP-3、RANKL水平。结果: RA-FLS中CXCL16、CXCR6蛋白表达水平均明显高于OA组和对照组(P<0.05),OA组和对照组间差异无统计学意义;重组人CXCL16(50、100、200 μg/L)刺激后RA-FLS增殖能力明显高于非刺激组(P均<0.05),OA组和对照组FLS经CXCL16刺激后细胞增殖水平无明显变化(P>0.05);200 μg/L CXCL16刺激后,RA-FLS表达pAKT/AKT明显增高;CXCL16(50、100、200 μg/L)刺激后,RA-FLS培养上清中IL-6和RANKL表达明显增加(P < 0.05),而MMP-3、TNF-ɑ水平无明显变化。结论:CXCL16及其受体在RA-FLS中表达增高,重组人CXCL16可促进RA-FLS增殖活化、分泌炎性因子增加,提示CXCL16参与了RA的滑膜炎症。

关键词: 关节炎,类风湿, 成纤维样滑膜细胞, CXCL16, CXCR6

Abstract: Objective:It has been found that serum CXCL16 concentration in rheumatoid arthritis (RA) patients are significantly higher than those in osteoarthritis (OA) and normal subjects, and are positively correlated with disease activity and bone erosion. However, how is CXCL16 involved in the pathogenesis of RA is unclear. To evaluate the expression of CXCL16 and its receptor CXCR6 in fibroblast-like synoviocytes (FLS) of rheumatoid arthritis (RA) patients, and to explore the role of CXCL16 in the proliferation of RA-FLS. Methods: FLS were isolated from knee synovial tissues obtained from 8 patients of RA, 7 osteoarthritis (OA) and 3 normal controls. The diagnosis of RA was in line with the 1987 American Rheumatology Association (ACR) RA classification criteria, osteoarthritis met the 1996 ACR revised knee osteoarthritis classification criteria. Control synovium were obtained from trauma caused knee joint injury in healthy individuals who required surgery. Human knee FLS were cultured by tissue explants adherent method.FLS between passages 3 and 5 were used in the experiment. Expression of CXCL16 and its receptor CXCR6 were performed in Western blot analysis. FLS proliferation follo-wing stimulation with TNF-α and different concentrations of CXCL16 was examined by cell counting kit-8 (CCK-8). Expression of phosphorylated AKT (pAKT) in RA-FLS stimulated by CXCL16 was quantified by Western blot. Different concentrations of recombinant human CXCL16 were added to the culture medium of RA-FLS. After 48 h culture, supernantants were collected, and TNF-α, IL-6, RANKL and MMP3 in culture supernatants of RA-FLS were determined by enzyme-linked immunosorbent assays (ELISA) operated following the kit instructions. Results: Expression of CXCL16 and CXCR6 in RA-FLS was significantly higher than that of OA and controls (P<0.05), but no significant difference was found between OA-FLS and control FLS. Proliferation of RA-FLS was markedly up-regulated after stimulation of CXCL16 (P <0.05). In the case of the CXCL16 stimulated OA-FLS and control FLS, the FLS proliferation remained basically unchanged. Expression of phosphorylated AKT in RA-FLS increased remarkably in condition of CXCL16 (50,100, 200 μg/L) stimulation. The levels of IL-6 and RANKL in culture supernatants of RA-FLS were obviously increased under CXCL16 (200 μg/L) stimulation, while TNF-α and MMP-3 levels in the culture supernatants remained unchanged after CXCL16 (200 μg/L) stimulation. Conclusion: This study shows that the expression of CXCL16 and its receptor was highly elevated in RA-FLS. Recombinant CXCL16 promoted RA-FLS proliferation and activation in vitro. All these indicate that CXCL16 play an important role in the pathogenesis of RA, anti-CXCL16 treatment may help to relieve inflammation and bone damage of RA patients. However, due to the limitations of this study, the role of CXCL16 and its receptors in RA-FLS remains to be elucidated by further research.

Key words: Arthritis, rheumatoid, Fibroblast-like synovial cell, CXCL16, CXCR6

中图分类号: 

  • R593.22
[1] 孙琳, 刘蕊, 刘湘源, 赵金霞, 徐宁, 龙丽, 栗占国. 类风湿关节炎患者外周血CXCL16的表达及临床意义[J]. 北京大学学报(医学版), 2010, 42(5): 591-592.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!